{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:35:54Z","timestamp":1793414154089,"version":"4.5.0"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T00:00:00Z","timestamp":1689292800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Data reporting on patients with Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) within the United States population is limited. We sought to evaluate the overt cerebrovascular disease burden among patients with CADASIL.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Harmonized electronic medical records were extracted from the TriNetX global health research network. CADASIL patients were identified using diagnostic codes and those with\/without history of documented stroke sub-types (ischemic stroke [IS], intracerebral hemorrhage [ICH], subarachnoid hemorrhage [SAH] and transient ischemic attack [TIA]) were compared. Adjusted odds ratios (OR) and 95% confidence intervals (CI) of stroke incidence and mortality associated with sex were computed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Between September 2018 and April 2020, 914 CADASIL patients were identified (median [IQR] age: 60 [50\u201369], 61.3% females); of whom 596 (65.2%) had documented cerebrovascular events (i.e., CADASIL-Stroke patients). Among CADASIL-Stroke patients, 89.4% experienced an IS, co-existing with TIAs in 27.7% and hemorrhagic strokes in 6.2%; initial stroke events occurred \u226465\u2009years of age in 71% of patients. CADASIL-Stroke patients (vs. CADASIL-non-Stroke) had higher cardiovascular and neurological (migraines, cognitive impairment, epilepsy\/seizures, mood disorders) burden. In age- and comorbidity-adjusted models, males had higher associated risk of stroke onset (OR: 1.37, CI: 1.01\u20131.86). Mortality risk was higher for males (OR: 2.72, CI: 1.53\u20134.84).<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Early screening and targeted treatment strategies are warranted to help CADASIL patients with symptom management and risk mitigation.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2023.1203985","type":"journal-article","created":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T20:28:00Z","timestamp":1689366480000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Lifelong cerebrovascular disease burden among CADASIL patients: analysis from a global health research network"],"prefix":"10.3389","volume":"14","author":[{"given":"Alan P.","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Potter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulaziz","family":"Bako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonika","family":"Tannous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudha","family":"Seshadri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise D.","family":"McCullough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhaan S.","family":"Vahidy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,14]]},"reference":[{"key":"ref1","year":"2011"},{"key":"ref2","year":"2023"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/383707a0","article-title":"Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia","volume":"383","author":"Joutel","year":"1996","journal-title":"Nature"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e0234797","DOI":"10.1371\/journal.pone.0234797","article-title":"Clinical and imaging features of patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy and cysteine-sparing NOTCH3 mutations","volume":"15","author":"Kim","year":"2020","journal-title":"PLoS One"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1136\/jnnp.2004.051847","article-title":"The prevalence of cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL) in the west of Scotland","volume":"76","author":"Razvi","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1212\/WNL.0b013e31824d586c","article-title":"The minimum prevalence of CADASIL in Northeast England","volume":"78","author":"Narayan","year":"2012","journal-title":"Neurology"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/ane.12266","article-title":"Changing clinical patterns and increasing prevalence in CADASIL","volume":"130","author":"Moreton","year":"2014","journal-title":"Acta Neurol Scand"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s00415-014-7533-2","article-title":"CADASIL in Central Italy: a retrospective clinical and genetic study in 229 patients","volume":"262","author":"Bianchi","year":"2015","journal-title":"J Neurol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3389\/fnagi.2020.00091","article-title":"Clinical and genetic aspects of CADASIL","volume":"12","author":"Mizuno","year":"2020","journal-title":"Front Aging Neurosci"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1002\/ana.410440506","article-title":"The phenotypic spectrum of CADASIL: clinical findings in 102 cases","volume":"44","author":"Dichgans","year":"1998","journal-title":"Ann Neurol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1600-0404.2008.01015.x","article-title":"Psychiatric disturbances in CADASIL: a brief review","volume":"118","author":"Valenti","year":"2008","journal-title":"Acta Neurol Scand"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1093\/brain\/awh282","article-title":"Long-term prognosis and causes of death in CADASIL: a retrospective study in 411 patients","volume":"127","author":"Opherk","year":"2004","journal-title":"Brain"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/B978-0-12-803058-5.00122-3","article-title":"CADASIL","volume-title":"Primer on Cerebrovascular Diseases","author":"Chabriat","year":"2017"},{"key":"ref14","article-title":"CADASIL","volume-title":"GeneReviews\u00ae","author":"Hack","year":"1993"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fneur.2021.756887","article-title":"Sex differences in cerebral small vessel disease: a systematic review and Meta-analysis","volume":"12","author":"Jim\u00e9nez-S\u00e1nchez","year":"2021","journal-title":"Front Neurol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1161\/STROKEAHA.111.631028","article-title":"Effects of gender on the phenotype of CADASIL","volume":"43","author":"Gunda","year":"2012","journal-title":"Stroke"},{"key":"ref17","year":"2021"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12916-017-0778-8","article-title":"Cerebral autosomal dominant Arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) as a model of small vessel disease: update on clinical, diagnostic, and management aspects","volume":"15","author":"Di Donato","year":"2017","journal-title":"BMC Med"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S1474-4422(09)70127-9","article-title":"Cadasil","volume":"8","author":"Chabriat","year":"2009","journal-title":"Lancet Neurol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10072-023-06773-1","article-title":"Antiplatelet use and CADASIL: a retrospective observational analysis","author":"Muppa","year":"2023","journal-title":"Neurol Sci"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1161\/hs0102.100885","article-title":"Cerebral microbleeds in CADASIL: a gradient-Echo magnetic resonance imaging and autopsy study","volume":"33","author":"Dichgans","year":"2002","journal-title":"Stroke"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.12.006","article-title":"Successful use of intravenous tissue plasminogen activator as treatment for a patient with cerebral autosomal dominant Arteriopathy with subcortical infarcts and leukoencephalopathy: a case report and review of literature","volume":"25","author":"Khan","year":"2016","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref23","year":""},{"key":"ref24","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1212\/WNL.0000000000201720","article-title":"Genetic causes of cerebral small vessel diseases: a practical guide for neurologists","volume":"100","author":"Manini","year":"2023","journal-title":"Neurology"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1111\/ene.14183","article-title":"Monogenic cerebral small-vessel diseases: diagnosis and therapy. Consensus recommendations of the European academy of neurology","volume":"27","author":"Mancuso","year":"2020","journal-title":"Euro J Neurol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1212\/WNL.96.15_supplement.2437","article-title":"Characterization of a large single-site USA CADASIL cohort (2437)","volume":"96","author":"Zitser-Koren","year":"2021","journal-title":"Neurology"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1203985\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,17]],"date-time":"2023-12-17T04:13:58Z","timestamp":1702786438000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1203985\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,14]]},"references-count":26,"alternative-id":["10.3389\/fneur.2023.1203985"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2023.1203985","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,14]]},"article-number":"1203985"}}